Skip to main content
. 2022 Aug 16;13:918083. doi: 10.3389/fphar.2022.918083

TABLE 4.

Pharmacokinetic parameters of GS-441524 in mice, rats, monkeys, and dogs after single IV and PO administration.

Species IV* PO**
CLp (mL/min/kg) Vdss (L/kg) Cmax (ng/mL) Tmax (h) AUC0-∞ (ng·h/mL) t1/2 (h) F (%)
Mouse*** 26 2.4 582 1.5 2,540 3.9 39
Rat 25 ± 1.6 2.2 ± 0.3 193 ± 57 3.8 ± 2.4 2,170 ± 643 3.4 ± 0.2 33 ± 9.8
Monkey 9.5 ± 1.0 1.1 ± 0.04 59.4 ± 18.1 2.0 ± 0 734 ± 138 7.7 ± 1.4 8.3 ± 1.6
Dog 4.1 ± 0.70 0.92 ± 0.078 6,010 ± 1,400 0.28 ± 0.19 19,000 ± 5,200 4.1 ± 1.1 85 ± 17

*IV, dose: 5 mg/kg for mouse and rat; 2 mg/kg for dog and monkey.

**PO, dose: 10 mg/kg for mouse and rat; 5 mg/kg for dog and monkey.

***Mean concentrations at each time point were used in the pharmacokinetic parameter calculation.